35 / 38
34
34
Diretrizes AMB
9. Lim W, Crowther MA, Eikelboom JW. Management of
antiphospholipid antibody syndrome: a systematic review. JAMA
2006;295:1050-7.
10. Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin or
anticoagulants for treating recurrent miscarriage in women without
antiphospholipid syndrome. Cochrane Database Syst Rev
2009;(1):CD004734.
11. Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial
J, et al. A randomized clinical trial of high-intensity warfarin vs.
Conventional antithrombotic therapy for the prevention of recurrent
thrombosis in patients with the antiphospholipid syndrome (WAPS).
J Thromb Haemost 2005;3:848-53.
12. Crowther MA, Wisloff F. Evidence based treatment of the
antiphospholipid syndrome II. Optimal anticoagulant therapy for
thrombosis. Thromb Res 2005;115:3-8.
13. Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis
J, et al. A comparison of two intensities of warfarin for the prevention
of recurrent thrombosis in patients with the antiphospholipid
antibody syndrome. N Engl J Med 2003;349:1133-8.
14. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ,
Hughes GR. The management of thrombosis in the antiphospholipid-
antibody syndrome. N Engl J Med 1995;332:993-7.
15. Rivier G, Herranz MT, Khamashta MA, Hughes GR. Thrombosis
and antiphospholipid syndrome: a preliminary assessment of three
antithrombotic treatments. Lupus 1994;3:85-90.
16. Derksen RH, de Groot PG, Kater L, Nieuwenhuis HK. Patients
with antiphospholipid antibodies and venous thrombosis should
receive long term anticoagulant treatment. Ann Rheum Dis
1993;52:689-92.
17. Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther
M, Derksen R, et al. Evidence-based recommendations for the
prevention and long-term management of thrombosis in
antiphospholipid antibody-positive patients: report of a task force at
the 13th International Congress on antiphospholipid antibodies.
Lupus 2011;20:206-18.
18. Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca
RR, et al. Antiphospholipid antibodies and subsequent thrombo-